Sumitomo Pharma Co., Ltd. (OTCMKTS:DNPUF – Get Free Report) dropped 23% during mid-day trading on Monday . The stock traded as low as $12.88 and last traded at $12.88. Approximately 100 shares traded hands during trading, a decline of 91% from the average daily volume of 1,054 shares. The stock had previously closed at $16.7350.
Sumitomo Pharma Stock Performance
The company has a 50-day simple moving average of $14.94 and a 200-day simple moving average of $12.05.
Sumitomo Pharma Company Profile
Sumitomo Pharma Co, Ltd., trading OTC under the ticker DNPUF, is a global pharmaceutical company headquartered in Osaka, Japan. It engages in the research, development, manufacturing and marketing of prescription medicines. As part of the broader Sumitomo Group, the company applies integrated drug discovery platforms and collaborative partnerships to bring innovative therapies to market.
The company’s portfolio encompasses central nervous system disorders, oncology, immunology and regenerative medicine.
Recommended Stories
- Five stocks we like better than Sumitomo Pharma
- Elon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)
- Forget AI, This Will Be the Next Big Tech Breakthrough
- Everyone’s watching Nvidia right now. Here’s why I’m excited.
- Trump’s new AI budget just passed — one stock could soar
- [How To] Invest Pre-IPO In SpaceX With $100!
Receive News & Ratings for Sumitomo Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sumitomo Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
